A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
OBJECTIVE: To determine the degree to which alpha-glucosidase inhibitors, with their unique mode of action primarily reducing postprandial hyperglycemia, offer an additional therapeutic approach in the long-term treatment of type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 1,946 patients (63...
Үндсэн зохиолчид: | Holman, R, Cull, C, Turner, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
1999
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients
-н: Holman, R, зэрэг
Хэвлэсэн: (1996) -
Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
-н: Davis, T, зэрэг
Хэвлэсэн: (2001) -
Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects
-н: Holman, R, зэрэг
Хэвлэсэн: (1999) -
Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.
-н: Retnakaran, R, зэрэг
Хэвлэсэн: (2006) -
UK prospective diabetes study
-н: Turner, R, зэрэг
Хэвлэсэн: (1996)